AU613337B2 - Immunoassay utilizing microparticle neutralization - Google Patents
Immunoassay utilizing microparticle neutralization Download PDFInfo
- Publication number
- AU613337B2 AU613337B2 AU10625/88A AU1062588A AU613337B2 AU 613337 B2 AU613337 B2 AU 613337B2 AU 10625/88 A AU10625/88 A AU 10625/88A AU 1062588 A AU1062588 A AU 1062588A AU 613337 B2 AU613337 B2 AU 613337B2
- Authority
- AU
- Australia
- Prior art keywords
- assay
- ligand
- microparticles
- sample
- neutralization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000011859 microparticle Substances 0.000 title claims abstract description 51
- 238000006386 neutralization reaction Methods 0.000 title abstract description 31
- 238000003018 immunoassay Methods 0.000 title description 16
- 238000003556 assay Methods 0.000 claims abstract description 63
- 239000003446 ligand Substances 0.000 claims abstract description 45
- 239000012472 biological sample Substances 0.000 claims abstract description 17
- 230000003472 neutralizing effect Effects 0.000 claims description 25
- 239000000523 sample Substances 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 16
- 208000002672 hepatitis B Diseases 0.000 claims description 13
- 101710132601 Capsid protein Proteins 0.000 claims description 12
- 230000027455 binding Effects 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 238000012790 confirmation Methods 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 13
- 230000009870 specific binding Effects 0.000 description 11
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 239000007790 solid phase Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ISCMYZGMRHODRP-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCN=C=N ISCMYZGMRHODRP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013584 assay control Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000002967 competitive immunoassay Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
- G01N33/5762—Hepatitis B core antigen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US641987A | 1987-01-21 | 1987-01-21 | |
| US006419 | 1987-01-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1062588A AU1062588A (en) | 1988-07-28 |
| AU613337B2 true AU613337B2 (en) | 1991-08-01 |
Family
ID=21720793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU10625/88A Ceased AU613337B2 (en) | 1987-01-21 | 1988-01-20 | Immunoassay utilizing microparticle neutralization |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0276719B1 (enExample) |
| JP (1) | JP2596959B2 (enExample) |
| AT (1) | ATE78598T1 (enExample) |
| AU (1) | AU613337B2 (enExample) |
| CA (1) | CA1306190C (enExample) |
| DE (1) | DE3872888D1 (enExample) |
| ES (1) | ES2033938T3 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0304238A3 (en) * | 1987-08-14 | 1991-10-09 | Ortho Diagnostic Systems Inc. | Method for detecting and confirming the presence of antibodies |
| US5064755A (en) * | 1988-08-04 | 1991-11-12 | Abbott Laboratories | Two-site confirmatory assay |
| DE69330785T2 (de) * | 1992-03-27 | 2002-06-20 | Abbott Laboratories, Abbott Park | Qualitätskontrolle für analytische verfahren |
| CA2627360C (en) * | 2005-10-29 | 2014-06-10 | Bayer Technology Services Gmbh | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0124050A1 (en) * | 1983-04-28 | 1984-11-07 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | A method of solid phase immunoassay incorporating a luminescent label |
| EP0158443A2 (en) * | 1984-03-13 | 1985-10-16 | Sekisui Kagaku Kogyo Kabushiki Kaisha | A latex for immunoserological tests and a method of producing the same |
| AU8004587A (en) * | 1986-10-23 | 1988-04-28 | Behringwerke Aktiengesellschaft | Porous solid phases having bioaffinity, a process for preparing porous solid phases having bioaffinity, and their use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL49752A (en) * | 1975-07-09 | 1979-07-25 | Kabi Ab | Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration |
| CA1268437A (en) * | 1984-12-21 | 1990-05-01 | Haruo Fujita | Method for purification of hbc antigen and method for measurement of hbc antibody by using said purified hbc antigen |
-
1988
- 1988-01-18 AT AT88100626T patent/ATE78598T1/de active
- 1988-01-18 EP EP88100626A patent/EP0276719B1/en not_active Expired - Lifetime
- 1988-01-18 CA CA000556734A patent/CA1306190C/en not_active Expired - Fee Related
- 1988-01-18 DE DE8888100626T patent/DE3872888D1/de not_active Expired - Fee Related
- 1988-01-18 ES ES198888100626T patent/ES2033938T3/es not_active Expired - Lifetime
- 1988-01-20 AU AU10625/88A patent/AU613337B2/en not_active Ceased
- 1988-01-21 JP JP63013466A patent/JP2596959B2/ja not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0124050A1 (en) * | 1983-04-28 | 1984-11-07 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | A method of solid phase immunoassay incorporating a luminescent label |
| EP0158443A2 (en) * | 1984-03-13 | 1985-10-16 | Sekisui Kagaku Kogyo Kabushiki Kaisha | A latex for immunoserological tests and a method of producing the same |
| AU8004587A (en) * | 1986-10-23 | 1988-04-28 | Behringwerke Aktiengesellschaft | Porous solid phases having bioaffinity, a process for preparing porous solid phases having bioaffinity, and their use |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0276719B1 (en) | 1992-07-22 |
| AU1062588A (en) | 1988-07-28 |
| ES2033938T3 (es) | 1993-04-01 |
| EP0276719A3 (en) | 1988-08-17 |
| EP0276719A2 (en) | 1988-08-03 |
| CA1306190C (en) | 1992-08-11 |
| DE3872888D1 (de) | 1992-08-27 |
| JPS63191960A (ja) | 1988-08-09 |
| ATE78598T1 (de) | 1992-08-15 |
| JP2596959B2 (ja) | 1997-04-02 |
| DE3872888T2 (enExample) | 1993-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5141848A (en) | Confirmatory immunoassay using microparticle separation | |
| EP0063810B1 (en) | New devices and kits for immunological analysis | |
| AU614109B2 (en) | Test method and reagent kit therefor | |
| US4184849A (en) | Mixed agglutination | |
| EP0267317B1 (en) | Method for the detection of proteins and viruses | |
| GB2045431A (en) | Immunoassay utilising two particulate reagents | |
| JPS6367661B2 (enExample) | ||
| AU648625B2 (en) | Test method and reagent kit therefor | |
| JP3363166B2 (ja) | 相互に対する極めて高い特異的親和性を有するペプチド対をイン・ビトロ診断分野に使用する方法 | |
| US6143510A (en) | Measuring method using whole blood sample | |
| CA2046130A1 (en) | Biologically active reagent, analytical element and methods for use of the reagent | |
| AU682478B2 (en) | Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand | |
| WO1987004794A1 (en) | Latex agglutination using avidin/biotin system | |
| EP0201211A1 (en) | Method and compositions for visual solid phase immunoassays based on luminescent microspheric particles | |
| JP3327488B2 (ja) | 被検体の免疫化学的測定方法 | |
| AU613337B2 (en) | Immunoassay utilizing microparticle neutralization | |
| CA1117414A (en) | Immunochemical ldh.sub.1 assay | |
| AU595899B2 (en) | Method for diagnostic immunoassay by solid phase separation | |
| US5637472A (en) | Hydrazine derivatized cells | |
| AU601674B2 (en) | A method for determining a ligand | |
| JPH0688822A (ja) | 水性試料中の被分析物の測定法、測定試薬及び測定試薬キット | |
| EP0260079A1 (en) | Method of assay | |
| JPH0382962A (ja) | Ｂ型肝炎ウィルスＣｏｒｅ抗原に対する抗体の検出方法 | |
| WO1993019369A1 (en) | Technique for prevention of false reactions in immunological testing |